SCHEMBL30075791

SCHEMBL30075791

CCCCOC(=O)N1CC(CSCC)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.39
▸ GBA2 Q9HCG7 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ ATM Q13315 1/20 0.37
▸ HRH2 P25021 1/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ BCHE P06276 1/20 0.35
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ HCAR2 Q8TDS4 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ NAAA Q02083 1/20 0.33
▸ KMT2A Q03164 1/20 0.32
▸ ECE1 P42892 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30129888 0.91 LMNA (0.47) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30075951 0.88 LMNA (0.44) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30129889 0.85 LMNA (0.47) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30075982 0.84 LMNA (0.46) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL4968757 0.82 LMNA (0.53) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL4968751 0.82 LMNA (0.53) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30129908 0.81 LMNA (0.51) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30129902 0.81 LMNA (0.51) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL29655416 0.79 LMNA (0.50) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL1633241 0.78 LMNA (0.56) LMNAPOLBSMN1; SMN2ALDH1A1GBA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081515-A1 INHIBITORS OF MUTANT FORMS OF EGFR Blueprint Medicines Corporation (US) 2022-11-02 — — EP disclosed
Send feedback